N. Rahman (Oxford, United Kingdom), P. Tarsia (Milano (MI), Italy)
Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion
Z. Iqbal (Peshawar, Pakistan), M. Umar (Peshawar, Pakistan), M. Yousaf (Peshawar, Pakistan)
|   |
Antibiotic strategy in pleural empyema in children: research of a consensus by DELPHI method
M. Leoni (Paris, France), I. Hau (Paris, France), S. Biscardi (Paris, France), C. Jung (Paris, France), C. Delestrain (Paris, France), G. Mangiapan (Paris, France), E. Nattes (Paris, France), F. Madhi (Paris, France), R. Epaud (Paris, France)
| |
The role of viruses in the development of pleural infection.
D. Arnold (Bristol, United Kingdom), T. Suri (Bristol, United Kingdom), F. Hamilton (Bristol, United Kingdom), A. Morley (Bristol, United Kingdom), S. Patole (Bristol, United Kingdom), A. Medford (Bristol, United Kingdom), P. Muir (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom)
| |
Outcomes of intrapleural tissue plasminogen activator (tPA) and deoxyribnuclease (DNase) for IPC-related pleural infection
D. Fitzgerald (Perth, Australia), S. Muruganandan (Perth, Australia), J. Uribe-Becerra (Boston, United States of America), S. Tsim (Glasgow, United Kingdom), R. Asciak (Oxford, United Kingdom), S. Walker (Bristol, United Kingdom), M. Azzopardi (Birtinya, Australia), N. Rahman (Oxford, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), A. Majid (Boston, United States of America), Y. Lee (Perth, Australia)
| |
IPC-related pleural infection vs. colonisation - to treat or not to treat?
K. Ferguson (Glasgow, United Kingdom), K. Blyth (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom)
| |
The role of Procalcitonin in management of pleural infections
S. Mohannad (kettering, United Kingdom), Y. Vali (kettering, United Kingdom), M. Naeem (kettering, United Kingdom), G. Tsaknis (kettering, United Kingdom), R. Reddy (kettering, United Kingdom)
| |
Prevalence of Epstein barr virus in pleural effusion patients attending tertiary care hospital.
R. Garg (Lucknow, India), D. Nasar Khan (Lucknow, India), A. Jain (Lucknow, India), R. Singh Kushwaha (Lucknow, India)
| |
Pleural empyema accuracy on Hospital Episode Statistics (HES): a validation study.
F. Hamilton (Bristol, United Kingdom), D. Arnold (Bristol, United Kingdom)
| |
Serum Procalcitonin for diagnosing and monitoring response in pleural infection
S. Mohammed (Kettering, United Kingdom), Y. Vali (Kettering, United Kingdom), M. Naeem (Kettering, United Kingdom), R. Reddy (Kettering, United Kingdom)
| |
Clinical features and prognosis of nontuberculous mycobacterial pleuritis
K. Yagi (Tokyo, Japan), A. Ito (Okayama, Japan), K. Fujiwara (Tokyo, Japan), E. Morino (Tokyo, Japan), I. Hase (Saitama, Japan), Y. Nakano (Kanagawa, Japan), T. Asakura (Tokyo, Japan), K. Furuuchi (Tokyo, Japan), S. Suzuki (Tokyo, Japan), T. Asami (Saitama, Japan), H. Namkoong (Tokyo, Japan), F. Saito (Tokyo, Japan), K. Morimoto (Tokyo, Japan), M. Ishii (Tokyo, Japan), H. Tateno (Saitama, Japan), K. Nishio (Kanagawa, Japan), Y. Oyamada (Tokyo, Japan), H. Sugiyama (Tokyo, Japan), T. Ishida (Okayama, Japan), A. Kurashima (Tokyo, Japan), N. Hasegawa (Tokyo, Japan)
| |
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
K. Tsuruno (Fukuoka, Japan), K. Tobino (Fukuoka, Japan)
| |
Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country
Y. Rahim (Karachi, Pakistan), M. Irfan (KARACHI, Pakistan)
| |
Fungal empyema: an uncommon disease with high mortality
N. Pestana Caires (Lisbon, Portugal), S. Campos Silva (Lisbon, Portugal), J. Eurico Reis (Lisbon, Portugal), R. Gerardo (Lisbon, Portugal), M. Pinto (Lisbon, Portugal), C. Flores (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal)
| |
Reccurent Haemorrhagic Pleural Effusion Due To Wuchereria Bancrofti
K. Utsav (Varanasi, India)
| |
Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection.
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), Y. Shoikhet (Barnaul, Russian Federation), A. Zharikov (Barnaul, Russian Federation)
| |
Modern opportunities to the diagnosis and treatment of recurrent respiratory papillomatosis with tracheal, bronchial and lung involvement
V. Molodtcova (Saint-Petersburgetersburgint, Russian Federation), I. Dvorakovskaya (Saint-Petersburg, Russian Federation), I. Platonova (Saint-Petersburg, Russian Federation), V. Karev (Saint-Petersburg, Russian Federation), A. Akopov (Saint-Petersburg, Russian Federation)
| |
Risk factors for parapneumonic effusion in community-asquired pneumonia
O. Brodskaya (Moscow, Russian Federation), A. Ball (Moscow, Russian Federation), M. Kevorkova (Moscow, Russian Federation), D. Glazova (Moscow, Russian Federation)
| |
Can Neutrophil/lymphocyte Ratio, C-reactive protein (CRP) and Procalcitonin predict the hospitalization time in patients with lower tract respiratory infections ?
A. Çetinkaya (Istanbul, Turkey), M. Uysal (Istanbul, Turkey), E. Niksarlioglu (Istanbul, Turkey), A. Durna (Istanbul, Turkey), N. Orhan Ozer (Istanbul, Turkey), G. Camsari (Istanbul, Turkey)
| |